Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

Author: Kotasek D.   Steger G.   Faught W.   Underhill C.   Poulsen E.   Colowick A.B.   Rossi G.   Mackey J.   for the AranespTM 980291 Study Group  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.39, Iss.14, 2003-09, pp. : 2026-2034

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content